Dr Reddy's to market Cosmederm's skincare range in India
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratorieshas entered a licensing and distribution agreement with Cosmederm Technologies, under which Dr Reddy's has exclusive rights to distribute Cosmederm's skincare range in India. The partnership covers two product lines – Refinity peel kits (glycolic acid 70%) and Cosmederm peel kits (glycolic acid 50%). Cosmederm offers potent, non-irritating skincare products in areas such as anti-ageing, acne, pruritis and rosacea. The alliance gives Dr Reddy's an entry to the aesthetic dermatology segment in India and consolidates its position in cosmeceuticals. The Indian market for aesthetic dermatology is estimated at about Rs1 billion ($22.5 million) and growing at more than 50% annually.